{"ModuleTitle": "Company Description", "CompanyName": "XOMA Corporation", "Symbol": "XOMA", "Address": "2910 SEVENTH ST, BERKELEY, California, 94710, United States of America", "Phone": "5126441170", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "XOMA Corporation (\"XOMA\"), a Delaware corporation, is a biotech royalty\r\naggregator. We have a sizable portfolio of economic rights to future potential\r\nmilestone and royalty payments associated with partnered pre-commercial\r\ntherapeutic candidates. Our portfolio was built through licensing our\r\nproprietary products and platforms from our legacy discovery and development\r\nbusiness, combined with acquisitions of rights to future milestones and\r\nroyalties that we have made since our royalty aggregator business model was\r\nimplemented in 2017. We expect that most of our future revenue will be based on\r\npayments we may receive for milestones and royalties related to these programs.\r\n\r\n                                       1\r\n\r\n  Table of Contents  \r\n\r\nOur strategy is to expand our pipeline by acquiring additional potential\r\nmilestone and royalty revenue streams on drug product candidates from third\r\nparties.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f10%2f0001558370-20-002286.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "James R. Neal", "title": "Chief Executive Officer & Director"}, {"name": "Thomas Burns", "title": "Chief Financial Officer & Senior VP-Finance"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}